Funneling: enhancing results of small-vessel stenting

Edo Kaluski, Christine Gerula, Preet Randhawa, Marc Klapholz

Research output: Contribution to journalArticlepeer-review


Until October 2008, coronary drug-eluting stents with a diameter of ≤2.5 mm were not approved by the FDA. Target vessels of ≤2 mm in diameter pose a major challenge in view of high restenosis rates when stented bare metal stents (BMS) are used and distal edge dissection when oversized stents are deployed. Described is a method ("funneling") to optimize stenting of small vessels. This strategy combines stenting the distal part of the lesion with short (8-12 mm length) 2-mm bare metal stent while stenting with a larger-diameter (≥2.5 mm) drug-eluting stent (DES) with considerable DES-BMS overlap (leaving only the distal 4-6 mm of the BMS not overlapped by a DES). The two stents create a funnel that is for the most part drug eluting. With funneling, both drug elution and larger diameter are attained, minimizing both edge dissection and restenosis.

Original languageEnglish (US)
Pages (from-to)255-258
Number of pages4
JournalCardiovascular Revascularization Medicine
Issue number4
StatePublished - Oct 2009

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


  • Drug eluting stents
  • PCI
  • stents

Fingerprint Dive into the research topics of 'Funneling: enhancing results of small-vessel stenting'. Together they form a unique fingerprint.

Cite this